Ascendis Pharma develops rare disease treatments based on its TransCon technology, including YORVIPATH and SKYTROFA. It last closed at $252.73 on Nov 20, down 1.26% on the day. Over the last 12 months ASND insiders bought $777K of stock on the open market and sold $10.8M, according to SEC Form 4 filings.
AI Auto Pilots
Is ASND in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold ASND.
From ASND's SEC filings, latest 20-F for the period ending Dec 31, 2025 (filed Feb 11). Last 12 months adds up the four latest quarters. Figures are in EUR. Per share figures are left out because the US listing can represent a different number of shares.
StreetAlpha's call on ASNDStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
ASND · as of the Nov 20 close · updated each morning
Uptrend
The stock sits between its 20 and 50 day averages. It is 5% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 49). The nearest support is the Pivot S1 at $250.64, and the nearest resistance the Pivot at $253.64.
Short trendBullish
Long trendBullish
MomentumFading
StretchNormal
VolatilityNormal, 3.1%/day
Key levels
$282.1552 week high+11.6%
$258.55Swing high (Aug 12)+2.3%
$257.6120 day average+1.9%
$255.74Pivot R1+1.2%
$253.64Pivot+0.4%
$252.73Last close
$250.64Pivot S1−0.8%
$250.04100 day average−1.1%
$248.31Swing low (Nov 4)−1.7%
$242.5850 day average−4.0%
$240.90200 day average−4.7%
$188.0852 week low−25.6%
Indicators
RSI (14)
48.56
Middle of its range
Neutral
MACD
6.05
Below its signal line
Bearish
Stochastic
37.6
Middle of its range
Neutral
ADX (14)
33.9
Trending down
Williams %R
-85.4
Oversold below −80, overbought above −20
Oversold
CCI (20)
-35.5
Oversold below −100, overbought above 100
Neutral
Rate of change
−1.6%
Change over 10 sessions
Bearish
ATR (14)
$7.80
Typical daily range, 3.1% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
Uptrend
Short trendBullish
Long trendBullish
MomentumImproving
StretchNormal
VolatilityNormal, 7.5%/day
Key levels
$282.1552 week high+11.6%
$258.55Swing high (Aug 12)+2.3%
$257.6120 day average+1.9%
$255.74Pivot R1+1.2%
$253.64Pivot+0.4%
$252.73Last close
$250.64Pivot S1−0.8%
$250.04100 day average−1.1%
$248.31Swing low (Nov 4)−1.7%
$242.5850 day average−4.0%
$240.90200 day average−4.7%
$188.0852 week low−25.6%
Indicators
RSI (14)
52.82
Middle of its range
Neutral
MACD
4.69
Above its signal line
Bullish
Stochastic
73.8
Middle of its range
Neutral
ADX (14)
14.7
No clear trend
Williams %R
-43.8
Oversold below −80, overbought above −20
Neutral
CCI (20)
66.3
Oversold below −100, overbought above 100
Neutral
Rate of change
−4.1%
Change over 10 sessions
Bearish
ATR (14)
$18.87
Typical daily range, 7.5% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for ASND
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ASND did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow ASND usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for ASNDHow many large options trades hit ASND, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in ASND in the last 90 days.
From SEC Form 4 filings by ASND's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ASND is in one of them and how their past ASND trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Ascendis Pharma A
Ascendis Pharma is a biopharmaceutical company based in Hellerup, Denmark. It develops medicines built on its TransCon technology, with a focus on rare endocrine conditions. Its approved products are YORVIPATH, for adults with hypoparathyroidism, and SKYTROFA, for people with growth hormone deficiency. The company also has product candidates in development for other growth disorders and in oncology, and it works with partners in Japan and China. Its customers are patients and the healthcare providers who prescribe its treatments.